Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Gore

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Lancet. Gastroenterology & Hepatology|June 27, 2017
An open letter to the Cochrane CollaborationCharles Gore,
The Lancet. Global Health|August 1, 2019
Antiviral treatment for hepatitis C: rebalancing cost, affordability, and availabilityGeoffrey Dusheiko, Charles Gore
The Lancet. Gastroenterology & Hepatology|November 5, 2017
Funding the elimination of viral hepatitis: donors neededCharles Gore, Jessica Hicks, Wouter Deelder
Central European Journal of Public Health|October 22, 2008
Addressing HCV infection in Europe: reported, estimated and undiagnosed casesSimona Merkinaite, Jeffrey V Lazarus, Charles Gore
Globalization and Health|July 3, 2024
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and responseTiwadayo Braimoh, Esteban Burrone, Charles Gore, et al.
BMJ (Clinical Research Ed.)|January 16, 2007
Chronic hepatitis CKosh Agarwal, Timothy J S Cross, Charles Gore
Journal of Medical Internet Research|September 7, 2006
Internet interventions for long-term conditions: patient and caregiver quality criteriaCicely Kerr, Elizabeth Murray, Fiona Stevenson, et al.
BMJ Global Health|September 5, 2023
Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider's storyCharles Gore, Sébastien Morin, John-Arne Røttingen, et al.
The Health Service Journal|January 19, 2012
Patient access. How to wipe out a growing killerKosh Agarwal, David Badcock, Owen Bowden-Jones, et al.
BMC Public Health|July 27, 2017
Associations between national viral hepatitis policies/programmes and country-level socioeconomic factors: a sub-analysis of data from the 2013 WHO viral hepatitis policy reportJeffrey V Lazarus, Ida Sperle, Kelly Safreed-Harmon, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Lancet. Gastroenterology & Hepatology|June 27, 2017
An open letter to the Cochrane CollaborationCharles Gore,
The Lancet. Global Health|August 1, 2019
Antiviral treatment for hepatitis C: rebalancing cost, affordability, and availabilityGeoffrey Dusheiko, Charles Gore
The Lancet. Gastroenterology & Hepatology|November 5, 2017
Funding the elimination of viral hepatitis: donors neededCharles Gore, Jessica Hicks, Wouter Deelder
Central European Journal of Public Health|October 22, 2008
Addressing HCV infection in Europe: reported, estimated and undiagnosed casesSimona Merkinaite, Jeffrey V Lazarus, Charles Gore
Globalization and Health|July 3, 2024
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and responseTiwadayo Braimoh, Esteban Burrone, Charles Gore, et al.
BMJ (Clinical Research Ed.)|January 16, 2007
Chronic hepatitis CKosh Agarwal, Timothy J S Cross, Charles Gore
Journal of Medical Internet Research|September 7, 2006
Internet interventions for long-term conditions: patient and caregiver quality criteriaCicely Kerr, Elizabeth Murray, Fiona Stevenson, et al.
BMJ Global Health|September 5, 2023
Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider's storyCharles Gore, Sébastien Morin, John-Arne Røttingen, et al.
The Health Service Journal|January 19, 2012
Patient access. How to wipe out a growing killerKosh Agarwal, David Badcock, Owen Bowden-Jones, et al.
BMC Public Health|July 27, 2017
Associations between national viral hepatitis policies/programmes and country-level socioeconomic factors: a sub-analysis of data from the 2013 WHO viral hepatitis policy reportJeffrey V Lazarus, Ida Sperle, Kelly Safreed-Harmon, et al.
Pageof 3